Yi Michael S, Tsevat Joel, Wilmott Robert W, Kotagal Uma R, Britto Maria T
Department of Interna Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio 45267-0535, USA.
J Pediatr. 2004 Jun;144(6):711-8. doi: 10.1016/j.jpeds.2004.02.032.
To investigate the impact of pulmonary exacerbations on the health-related quality of life (HRQOL) of patients with cystic fibrosis (CF) and to elucidate factors that are associated with changes in HRQOL post-exacerbation.
Participants completed questionnaires at a pre-exacerbation visit, at the beginning of the exacerbation, and at the post-exacerbation visit. To measure HRQOL, we used the Child Health Questionnaire-Parent Form (PF-50) and the Medical Outcomes Study Short Form-36 (SF-36). We examined demographic, clinical, and treatment-related predictor variables for association with change in Physical Summary (PhS) and Psychosocial Summary (PsS) HRQOL scores after an exacerbation.
We collected data from 48 subjects. Patients experiencing exacerbations who were treated as outpatients had a mean (SD) age of 19.5 (12.7) years and a mean pre-exacerbation forced expiratory volume in 1 second (FEV(1)) of 70% (36%) of predicted; 53% were female. Patients treated as inpatients had a mean age of 14.6 (5.5) years and a mean FEV(1) of 56% (24%); 56% were female. In univariate analyses, exacerbations were associated with a statistically significant decrease in FEV(1) (-10.0%) and PhS scores (-4.5 points). PsS scores did not significantly change with exacerbations (-0.7 points). In multivariable analyses examining change between pre-exacerbation and post-exacerbation visits, no variables were significantly associated with change in PhS scores. However, not being hospitalized for the exacerbation was associated with deterioration in PsS scores, and being hospitalized was associated with improvement in PsS scores (beta coefficient: 9.4; P <.01) by the post-exacerbation visit. Results were similar from the exacerbation to the post-exacerbation visit.
In patients with CF, on average, pulmonary exacerbations affect physical HRQOL more than psychosocial HRQOL. Being hospitalized for exacerbations is associated with improvement in psychosocial HRQOL after exacerbations, whereas not being hospitalized is associated with deterioration.
研究肺部加重期对囊性纤维化(CF)患者健康相关生活质量(HRQOL)的影响,并阐明与加重期后HRQOL变化相关的因素。
参与者在加重期前就诊时、加重期开始时和加重期后就诊时完成问卷。为了测量HRQOL,我们使用了儿童健康问卷家长版(PF-50)和医学结局研究简明健康调查36项量表(SF-36)。我们检查了人口统计学、临床和治疗相关的预测变量,以确定其与加重期后身体总结(PhS)和心理社会总结(PsS)HRQOL评分变化的相关性。
我们收集了48名受试者的数据。门诊治疗的加重期患者平均(标准差)年龄为19.5(12.7)岁,加重期前1秒用力呼气量(FEV₁)平均为预测值的70%(36%);53%为女性。住院治疗的患者平均年龄为14.6(5.5)岁,平均FEV₁为56%(24%);56%为女性。在单变量分析中,加重期与FEV₁(-10.0%)和PhS评分(-4.5分)的统计学显著降低相关。PsS评分在加重期无显著变化(-0.7分)。在多变量分析中,检查加重期前和加重期后就诊之间的变化,没有变量与PhS评分变化显著相关。然而,加重期未住院与PsS评分恶化相关,住院与加重期后就诊时PsS评分改善相关(β系数:9.4;P<.01)。从加重期到加重期后就诊的结果相似。
在CF患者中,平均而言,肺部加重期对身体HRQOL的影响大于心理社会HRQOL。因加重期住院与加重期后心理社会HRQOL改善相关,而未住院则与恶化相关。